Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 5, 2007, Pages 560-563

  Bell, David J ^a,d   Kapitao, Yamika ^a   Sikwese, Rosemary ^b   Van Oosterhout, Joep J ^b   Lalloo, David G ^c  

^a MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^b UNIVERSITY OF MALAWI   (Malawi)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adherence; Antiretroviral therapy; HIV; Medication event monitoring system (MEMS); Pill counting

Indexed keywords

LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; GOVERNMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HOSPITAL; SELF REPORT; SEX RATIO; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTI-RETROVIRAL AGENTS; DRUG MONITORING; FEMALE; HIV INFECTIONS; HOSPITALS, MUNICIPAL; HUMANS; MALAWI; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF ADMINISTRATION; SENSITIVITY AND SPECIFICITY;

EID: 34548100503     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3180decadb     Document Type: Article

References (12)

1. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417-1423.
2. Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17:1925-1932.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
4. Harries AD, Nyangulu DS, Hargreaves NJ, et al. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet. 2001;358:410-414.
5. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181-1183.
6. Garcia DO, Knobel H, Carmona A, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105-110.
7. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939-941.
8. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679-690.
9. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100-1102.
10. Bova CA, Fennie KP, Knafl GJ, et al. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9:103-110.
11. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
12. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269-277.